This study summarizes approaches that mitigate liver fibrosis/cirrhosis through the anti-pyroptosis pathway, including inhibitors targeting NLRP3, GSDMD, and caspases in the pyroptosis pathway, natural plant compounds and biomaterials (SCs and exosomes). Here, GSDMD is linked to Cirrhosis.